CD9 ApS: Financial statements 2022
CVR: 28127146
CD9 ApS (CVR 28127146) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -379,073 and a net result of DKK -542,950 compared with DKK -450,624 the year before. Equity amounted to DKK 141,069. The solvency ratio was 1.4%.
- Gross Profit
- -379,073 kr.
- Profit/Loss
- -542,950 kr.
- Equity
- 141,069 kr.
- Total Assets
- 9,792,436 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -379 t. | -543 t. | 141 t. | - |
| 2021 | - | -260 t. | -451 t. | 684 t. | - |
| 2020 | - | -216 t. | -401 t. | 135 t. | - |
| 2019 | - | -211 t. | -382 t. | 536 t. | - |
| 2018 | - | -235 t. | -217 t. | 918 t. | - |
Keep an eye on CD9 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
CD9 ApS has published its annual report for 2021. Gross profit came to DKK -259,795, and the net result was DKK -450,624.
About CD9 ApS
CD9 ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2004. The company is registered under the industry Køb og salg af egen fast ejendom. The management consists of Casper Munksø Thomsen. The company is owned by ApS af 25.06.2021. In 2025, the company reported a gross profit of DKK 2,106,276 and a net result of DKK 10,839,026 compared with DKK -1,109,456 the year before. Equity amounted to DKK 10,171,679.
